Jeremy Webster > Mewburn Ellis LLP > Manchester, England > Lawyer Profile
Mewburn Ellis LLP Offices
MANCHESTER ONE
53 PORTLAND STREET
MANCHESTER
M1 3LD
England
- Firm Profile
- Go to...
Jeremy Webster
Work Department
Head of Chemistry
Position
Partner, Patent Attorney, Chemistry
Career
Jeremy has over 15 years’ experience in chemistry and materials science patents, with a focus on polymers, composites and advanced materials, as well as consumer products. He has an enviable success rate with opposition and appeals and regularly represents clients at oral proceedings before the EPO. He provides early input to help ensure that appropriate and persuasive data is presented and works with a wide range of clients on invention capture and filing strategy, as well as driving efficiency and adding value in strategic portfolio management. Jeremy heads up the firm’s Chemistry practice group and is a member of our Management Board.
Jeremy’s clients include Japan-based multinational chemical and materials companies, large consumer goods businesses and universities.
Education
Jeremy has a degree and PhD in chemistry from the University of Nottingham. He qualified as a Chartered Patent Attorney and European Patent Attorney in 2005.
Lawyer Rankings
London > TMT (technology, media and telecoms) > PATMA: Patent attorneys
Mewburn Ellis LLP’s ‘excellent team’ benefits from the firm’s strong geographical footprint; with offices in London, Bristol, Manchester, Cambridge, and Munich, the practice is able to seamlessly advise clients on UK and German patent filing and prosecution matters, in addition to opposition proceedings before the EPO. Manchester-based Graeme Moore leads the growing engineering and ICT group, while Bristol-based Simon Kiddle heads up the life sciences team, which is notable for its expertise in emerging technical areas, such as bioinformatics, advanced therapeutics, antibodies, and precision medicine. Jeremy Webster leads the chemistry group from Manchester, which handles a wide range of chemical innovation patents, from dyes, drugs, and catalysts, to composites, polymers, and pesticides. Biopharma specialist Robert Andrews remains as the firm’s first chief inclusion and diversity officer.